-Radu Vasilcanu Researcher Activity Profile

Research Author Detailed Information 

Radu Vasilcanu Publication Rate By Year

Radu Vasilcanu has published 1 paper(s) in 2007, 3 paper(s) in 2008, for a total of 4 research publications in total.

Radu R Vasilcanu Author Information

LAST NAME: vasilcanu

FIRST NAME: Radu

INITIALS: r

AFFILIATION:

Papers

Radu Vasilcanu's Publication Record

1. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. Year Published: 2007
Department of Oncology and Pathology, Division of Cellular and Molecular Tumor Pathology, CCK, R8:04, Karolinska Hospital, SE-171 76 Stockholm, Sweden, and Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. Leonard.Girnita@ki.s
2. Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin. Year Published: 2008
Department of Oncology-Pathology, Cellular and Molecular Tumor Pathology, Cancer Center Karolinska, CCK R8:04, Karolinska Institutet, S-17176, Stockholm, Sweden. leonard.girnita@ki.se.
3. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin. Year Published: 2008
Department of Oncology-Pathology, Cellular and Molecular Tumor Pathology, Cancer Center Karolinska, CCK R8:04, Karolinska Institutet, S-17176, Stockholm, Sweden.
4. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1. Year Published: 2008
Department of Oncology and Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.